Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1,001 - 1,050 out of 11,358

Document Document Title
WO/2007/005000A1
The invention relates to methods of synthesizing 2-substituted azole compunds of formula (I). The invention is also relates to compounds of formula (I) and to intermediate compounds in the synthesis method.  
WO/2007/002173A1
One aspect of the invention relates to the design, synthesis and biological activity of novel HIV-1 protease inhibitors incorporating N-phenyloxazolidine-5-carboxamides into the (hydroxyethylamino)sulfonamide scaffold as P2 ligands. For ...  
WO2005012297A9
Leukotriene A4 hydrolase (LTA4H) inhibitors of Formula (I), compositions containing them, and their use for the inhibition of LTA4H enzyme activity and the treatment, prevention or inhibition of inflammation and/or conditions associated ...  
WO/2007/000235A1
The invention relates to alkoxymethyl-substituted benzoic acid derivatives and to the physiologically compatible salts thereof and physiologically functional derivatives thereof. The invention also relates to compounds of formula (I), wh...  
WO2006091848A3
The present invention provides an isolated linezolid (1) impurity, bis-linezolid (4), preparation thereof and its use as a reference standard.  
WO2005087752A8
The invention relates to novel aminoalkanol derivatives and also to methods of treating at least one disease, disorder, or condition associated with amyloidosis using such compounds. Amyloidosis refers to a collection of diseases, disord...  
WO/2006/138660A3
The invention relates to substituted adamantane compounds of formula (I), pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferati...  
WO/2006/138328A1
The present invention provides a convergent process for the preparation of a family of antidiabetic phenoxy-substituted phenoxybenzyl oxazolidinediones shown as structure I. The compounds are selective PPAR gamma partial agonists (SPPARM...  
WO2005072376A3
One aspect of the present invention relates to ionic liquids comprising an anionic sweetener. Another aspect of the present invention relates to the use of an ionic liquid of the present invention comprising a pendant Bronsted-acidic gro...  
WO2006082597A3
The present invention discloses crystalline Polymorphic Form I of compound 5-(3,5- dimethylphenoxy-) methyl)-2-oxazolidinone, characterized by x-ray diffraction pattern having peaks at 10.355, 14.285,18.625, 19.030, 20.810 and 22.475± 0...  
WO2006047438A3
Certain novel 3-(dihaloalkenyl)phenyl derivatives have unexpected insecticidal activity. These compounds are represented by formula (I), where R through R5, a, b, D, E, G and U are fully described herein. In addition, compositions compri...  
WO/2006/134955A1
A compound represented by the general formula (1) or (100), a salt thereof or a hydrate of the compound or salt, which is excellent in cell adhesion-inhibitory effect and cell infiltration-inhibitory effect: (1) (100) wherein R10 represe...  
WO2006069154A3
The present invention relates to novel, non-secosteroidal, phenyl-benzoxazole compounds of Formula (I) wherein the variables R, R', RP, RP3, LP1, LP2, ZP, RB, RB', LXB and ZXB are as hereinafter defined, their preparation, pharmaceutical...  
WO/2006/132173A1
Disclosed is an organic electroluminescent device (organic EL device) having an improved luminous efficiency, an adequate driving stability and a simple structure. Also disclosed is an organic metal complex suitable for such an organic e...  
WO/2006/133216A2
This invention relates to non-steroidal compounds that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds.  
WO/2006/133216A3
This invention relates to non-steroidal compounds that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of such compounds.  
WO2006102674A3
Various azetidinone, pyrrolidine, imidazolidine, and oxazolidine derivative are described, as are pharmaceutical compositions containing these compound and their use for preparing medicaments for the treatment of hypercholesterolemia  
WO/2006/131233A1
The invention relates to benzooxazole-2-on derivatives of general formula (I) with the meanings indicated in the description, the pharmaceutically usable salts thereof, and the use thereof as medicinal substances.  
WO/2006/133326A1
Compounds having the structure of formula I are described. The compounds can inhibit hepatitis C virus (HCV) replication, and in particular can inhibit the function of the HCV NS5A protein.  
WO2006058088A3
In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and methods for their use provided. In one aspect of the invention, compounds and compositions useful in...  
WO/2006/129164A1
This invention provides a compound of the formula (I): wherein A=B=D represents NR10-C(O)-NR9, S-C(O)-NR9, NR9-C(O)-S, NR9-C(O)-O, CR10-C(O)-NR9, 0-C(O)-NR9, NR10-C(O)-CR9, NR10-NR9-C(O), C(O)-NR9-NR10, NR10-N=CR9, N=N-CR9, NR10-CR9=N, N...  
WO/2006/129649A1
A process for producing optically active butyric acid compounds and intermediates for the production of the compounds in high yields at high optical purities. A process for the production of compounds (6), characterized by comprising pre...  
WO2006017409A3
Compounds represented by Formula I: (wherein A, B, D, P, Q, R1, R2, R3, W and Y are described herein) or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such a...  
WO/2006/127503A3
The present invention provides compounds useful, for example, for modulating insulin levels in a subject, having the general formula I: wherein Q is an optionally substituted phenyl; L is a bond or O; P is a benzene or an optionally subs...  
WO2006103045B1
The present invention relates to compounds comprising an oxazole or thiazole moiety of formula (I), processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as H3 -receptor ligands, Formula (I), ...  
WO/2006/127909A3
The present invention relates to polymorphic forms of ( S ) -l-cyanobutan-2-yl ( S ) -1- ( 3 - ( 3 - ( 3 -methoxy-4- ( oxazol-5- yl ) phenyl ) urei do ) phenyl ) ethyl carbamate , pharmaceutical compositions thereof , processes to prepar...  
WO2006110155A8
Novel crystalline forms of Linezolid, designated as Form TIII, Form V, Form VI, Form IX, Form X, Form XII, Form XIV, Form XVII, and Form XVIII, are disclosed. The novel crystalline forms are characterized by powder X-ray diffraction, FTI...  
WO/2006/127503A2
The present invention provides compounds useful, for example, for modulating insulin levels in a subject, having the general formula I: wherein Q is an optionally substituted phenyl; L is a bond or O; P is a benzene or an optionally subs...  
WO2006094770A3
The present invention is directed to a process for the preparation of (4S)- or (4R)-2,2-dimethyl-4-(2-hydroxethyl)oxazolidine-3-carboxylic acid alkyl esters. The invention is further directed to an intermediate product from which those a...  
WO/2006/127893A2
The present invention relates to processes for the production of 4-(biphenylyl)azetidin-2-one phosphonic acid derivatives of formula.  
WO/2006/127893A3
The present invention relates to processes for the production of 4-(biphenylyl)azetidin-2-one phosphonic acid derivatives of formula.  
WO/2006/125337A1
The present invention relates to &agr , β- and β, &gammad -unsaturated carboxylates and the use as herbicide thereof. The said compounds are shown below as general formula (I, II). Wherein: R1 is selected from C1-C4alkyl; R2 is selecte...  
WO/2006/127909A2
The present invention relates to polymorphic forms of ( S ) -l-cyanobutan-2-yl ( S ) -1- ( 3 - ( 3 - ( 3 -methoxy-4- ( oxazol-5- yl ) phenyl ) urei do ) phenyl ) ethyl carbamate , pharmaceutical compositions thereof , processes to prepar...  
WO/2006/125687A1
The invention relates to heteroaroyl-substituted serine amides of formula (I), wherein the variables A and R1 to R6 have the meanings indicated in the description, the agriculturally useful salts thereof, methods and intermediate product...  
WO2006105217A3
Heterocyclic-substituted tricyclics of the formula or a pharmaceutically acceptable salt or solvate of said compound, isomer or racemic mixture wherein represents an optional double bond, the dotted line is optionally a bond or no bond, ...  
WO/2006/122949A1
Malononitrile compounds of formula (I) wherein R1 is H, (halo)alkyl, (halo)alkenyl, or (halo)alkynyl; R2 is H1 CN, (halo)alkyl, (halo)alkenyl, (halo)alkynyl, (halo)cycloalkyl, or (halo)alkoxy; R3 and R4 are H, (halo)alkyl, (halo)alkenyl,...  
WO2006081034A3
Novel compounds and methods of using those compounds for the treatment of inflammatory conditions, hyperproliferative diseases, cancer, and diseases characterized by hyper-vascularization are provided. ][n a preferred embodiment, modulat...  
WO/2006/122020A3
The present invention relates to processes for the production of 4-biphenylylazetidin-2-one derivatives of formula (I).  
WO/2006/122216A3
The present invention relates to processes for the production of phenolic 4-biphenylylazetidin-2-one derivatives Formula (1)  
WO/2006/122250A2
The present invention is directed to compounds of formula (I) (I) wherein variables W, X, Y, D, A, n, R1, R2 and R9 are as defined in the description.  
WO2006086705B1
The present invention relates to a series of substituted bis aryl and heteroaryl compounds of formula (I): Wherein X, Y, Z, A, B, D, Ar, R1 and R2 are as defined herein. The compounds of this invention are selective 5HT2A antagonists, an...  
WO/2006/121019A1
A complex of a compound represented by the general formula (I) and vanadium or a vanadium compound: (I) wherein R1 and R2 independently represent a hydrocarbon group which may be substituted, provided that at least one of R1 and R2 is a ...  
WO/2006/122250A3
The present invention is directed to compounds of formula (I) (I) wherein variables W, X, Y, D, A, n, R1, R2 and R9 are as defined in the description.  
WO2006076415A3
The application discloses a novel process for the preparation of himbacine analogs useful as thrombin receptor antagonists. The process is based in part on the use of a base-promoted dynamic epimerization of a chiral nitro center. The ch...  
WO/2006/122020A2
The present invention relates to processes for the production of 4-biphenylylazetidin-2-one derivatives of formula (I).  
WO2006083924A8
1-Acylamino-2-hydroxy-3-amino-?-arylalkanes of formula I. and the salts thereof, have renin-inhibiting properties and can be used as antihypertensive, medicinally active ingredients.  
WO/2006/121962A1
This invention describes the discovery and synthesis of N-thiolated 2-oxazolidinones as a new class of anti bacterial agents. These compounds can be synthesized from 2- oxazolidinones by Ndeprotection and N-sulfenylation. These new subst...  
WO2006028963A3
The present invention relates to substituted heterocyclic compounds and compositions comprising a substituted heterocyclic compound. The present invention also relates to methods for preventing or treating various diseases and disorders ...  
WO2006091848A9
The present invention provides an isolated linezolid (1) impurity, bis-linezolid (4), preparation thereof and its use as a reference standard.  
WO2005074603A3
A compound of Formula (I), wherein the substituents are as defined herein, which are useful as kinase inhibitors.  

Matches 1,001 - 1,050 out of 11,358